Fraser Stryker Law Firm
General
Cases15
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
Transport., E-Comm.ChemicalMech Eng, Manuf
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 05/30/24 | TEXT ORDER granting 24 Motion to Restrict pursuant to the E-Government Act. Defendant's Reply Brief in Support of its Motion to Dismiss the Complaint shall remain restricted to case participants and court users. Ordered by Magistrate Judge Michael D. Nelson. (SMN) (Entered: 05/30/2024) | |
| 08/18/22 | ORDER ON STIPULATION OF DISMISSAL - This matter is before the Court on the parties' Stipulation of Dismissal. Filing 99 . Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii), this case is dismissed with prejudice, each party to bear its own fees and costs. Ordered by Judge Brian C. Buescher. (LKO) (Entered: 08/18/2022) | |
| 08/21/20 | Final Civil Docket 08-18-2022 | |
| 04/26/17 | ANSWER to 1 Complaint, Affirmative Defenses, And, COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 04/26/2017) | |
| 03/13/17 | ORDER re 7 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2017 filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Mary Pat Thynge on 3/13/17. (cak) (Entered: 03/13/2017) | |
| 03/13/17 | STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2017 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 03/13/2017) | |
| 03/06/17 | SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Teva Pharmaceuticals USA, Inc. served on 3/6/2017, answer due 3/27/2017. (Noreika, Maryellen) (Entered: 03/06/2017) | |
| 05/04/18 | Letter to The Honorable Sherry R. Fallon from Maryellen Noreika regarding postponement of May 7, 2018 status conference. (Noreika, Maryellen) (Entered: 05/04/2018) | |
| 04/30/18 | NOTICE OF SERVICE of (1) Teva Pharmaceuticals USA, Inc.s Responses and Objections to Novo Nordisk and Novo Nordisk A/Ss Notice of Deposition under Federal Rule of Civil Procedure 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 04/30/2018) | |
| 04/26/18 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, John Scheibeler, Ryan P. Johnson, Laura T. Moran, and So Yeon Choe - filed by Novo Nordisk A/S, Novo Nordisk Inc.. Motions referred to Sherry R. Fallon.(Noreika, Maryellen) (Entered: 04/26/2018) |